BR9608473A - Complexo organometálico do ferro, composição para o tratamento do paludismo, e, utilização de um composto - Google Patents

Complexo organometálico do ferro, composição para o tratamento do paludismo, e, utilização de um composto

Info

Publication number
BR9608473A
BR9608473A BR9608473-1A BR9608473A BR9608473A BR 9608473 A BR9608473 A BR 9608473A BR 9608473 A BR9608473 A BR 9608473A BR 9608473 A BR9608473 A BR 9608473A
Authority
BR
Brazil
Prior art keywords
malaria
compound
treatment
composition
iron complex
Prior art date
Application number
BR9608473-1A
Other languages
English (en)
Inventor
Jacques Brocard
Jacques Lebibi
Lucien Maciejewski
Original Assignee
Univ Lille Sciences Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9478836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9608473(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Lille Sciences Tech filed Critical Univ Lille Sciences Tech
Publication of BR9608473A publication Critical patent/BR9608473A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPLEXO ORGANOMETáLICO DO FERRO, COMPOSIçãO PARA O TRATAMENTO DO PALUDISMO, E, UTILIZAçãO DE UM COMPOSTO". A invenção refere-se aos complexos organometálicos do ferro compreendendo pelo menos um dos elementos estruturais de base característicos de uma molécula possuindo propriedades antipalúdicas como a quinina, a cloroquinina, ou a nepacrina assim como um ou vários átomos de ferro. Mais particularmente, os complexos de acordo com a invenção são caracterizados em que eles compreendem um ou vários grupos ferrocenos.
BR9608473-1A 1995-05-10 1996-05-10 Complexo organometálico do ferro, composição para o tratamento do paludismo, e, utilização de um composto BR9608473A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9505532A FR2733985B1 (fr) 1995-05-10 1995-05-10 Complexes organometalliques du fer antipaludiques
PCT/FR1996/000721 WO1996035698A1 (fr) 1995-05-10 1996-05-10 Complexes organometalliques du fer antipaludiques

Publications (1)

Publication Number Publication Date
BR9608473A true BR9608473A (pt) 1999-11-30

Family

ID=9478836

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608473-1A BR9608473A (pt) 1995-05-10 1996-05-10 Complexo organometálico do ferro, composição para o tratamento do paludismo, e, utilização de um composto

Country Status (14)

Country Link
US (1) US6127543A (pt)
EP (1) EP0824536B1 (pt)
JP (1) JP4394163B2 (pt)
AP (1) AP953A (pt)
AT (1) ATE204581T1 (pt)
AU (1) AU718946B2 (pt)
BR (1) BR9608473A (pt)
DE (1) DE69614679T2 (pt)
DK (1) DK0824536T3 (pt)
ES (1) ES2163022T3 (pt)
FR (1) FR2733985B1 (pt)
OA (1) OA10535A (pt)
PT (1) PT824536E (pt)
WO (1) WO1996035698A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205455D0 (en) 2002-03-07 2002-04-24 Molecular Sensing Plc Nucleic acid probes, their synthesis and use
FR2952823B1 (fr) 2009-10-30 2012-04-20 Sanofi Aventis Utilisation de la ferroquine dans le traitement ou la prevention du paludisme
FR2951945B1 (fr) 2009-11-05 2013-08-09 Sanofi Aventis Composition pharmaceutique
FR2961209B1 (fr) * 2010-06-11 2013-03-01 Sanofi Aventis Procede de synthese de la ferroquine par amination reductrice convergente.
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1470210A (en) * 1974-10-30 1977-04-14 Edwards E Organometallic derivatives of penicillin
DE2815930A1 (de) * 1978-04-13 1979-10-18 Bayer Ag Duengemittel zur versorgung von pflanzen mit eisen
EP0214933A3 (de) * 1985-09-03 1989-05-24 Ciba-Geigy Ag Kombinationspräparate zur Behandlung von Malaria

Also Published As

Publication number Publication date
AU5903796A (en) 1996-11-29
PT824536E (pt) 2002-02-28
JP4394163B2 (ja) 2010-01-06
DE69614679T2 (de) 2002-06-27
DK0824536T3 (da) 2001-12-17
EP0824536A1 (fr) 1998-02-25
US6127543A (en) 2000-10-03
ES2163022T3 (es) 2002-01-16
DE69614679D1 (de) 2001-09-27
FR2733985B1 (fr) 1997-07-18
OA10535A (fr) 2002-04-26
ATE204581T1 (de) 2001-09-15
AP953A (en) 2001-04-02
JPH11511738A (ja) 1999-10-12
AU718946B2 (en) 2000-05-04
WO1996035698A1 (fr) 1996-11-14
EP0824536B1 (fr) 2001-08-22
FR2733985A1 (fr) 1996-11-15
AP9701141A0 (en) 1998-01-31

Similar Documents

Publication Publication Date Title
BR0011678A (pt) Composições farmacêuticas compreendendo complexos de metal
DE69914928D1 (de) Polymerkomplexe von glukuronoglukanen
BR9814570A (pt) Composição biostática e revestimento para reduzir e evitar aderência bacteriana e microbiana, e, processo para preparar um artigo biostático.
DE69504695T2 (de) Silyl-kationische polymerisationsaktivatoren für metallocenkomplexe
BR0312464A (pt) Inibidores de tirosina quinases
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
BR0213843A (pt) Derivado de quinazolina, processo para a preparação de um derivado de quinazolina, composição farmacêutica, e, uso de um derivado de quinazolina
BR9814857A (pt) Processos para tratar leucemia, câncer sólido eleucemia, linfoma ou tumores sólidos em umhumano, e para fabricar uma composiçãofarmacêutica estéril, e, a respectiva composiçãofarmacêutica estéril
CA2332054A1 (en) Platinum complex, its preparation and therapeutic application
BR9914843A (pt) Composições e processos para a preparação de dispersões e processos para o uso das dispersões
MX9501157A (es) Acetamidas, proceso para su preparacion y preparaciones farmaceuticas que las contienen.
BR9608473A (pt) Complexo organometálico do ferro, composição para o tratamento do paludismo, e, utilização de um composto
TR199700999T1 (xx) Askomisinler.
BR0007275A (pt) Naftopiranos e fenantropiranos anelados em c5-c6com um grupo bicìclico e composições e matrizes
NO934761L (no) Antidepresjons- og antiparkinsonismeforbindelser
ATE166647T1 (de) Bis-naphthalimide für die behandlung von krebs
IT1241673B (it) Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
IE33330L (en) Bis (trifluoromethyl) stilbenes.
BR9912158A (pt) Conjugado de polipeptìdeo-polìmero, composição industrial, uso de um conjugado, e, método para melhorar o desempenho de lavagem de um polipeptìdeo.
IT1304183B1 (it) Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
BR0010086A (pt) Composições, utilização de um ou vários agentes estabilizantes, processo de preparação de composições estabilizadas, e, utilização das composições
FI895703A0 (fi) -olefiinien polymerointiin tarkoitettu prokatalyyttikompositio, sen valmistus ja käyttö
CY1112050T1 (el) Νεα 2-αλογονοποιημενα παραγωγα της 5-0- δεσοσαμινυλερυθρονολιδης α, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
KR960013376A (ko) 철과 디프룩토오스를 함유하는 빈혈치료제
KR970707165A (ko) 양이온성 중합체(cationic polymer)

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/08/2006, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.061556/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132361-55.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU:UNIVERSITE DES SCIENCES ET TECHNOLOGIES DE LILLE, WYETH HOLDINGS CORPORATION, YEDA RESEARCH AND DEVELOPMENT CO LTD.

B21B Extinction acc. art. 78, item ii - on waiver by the patentee, without prejudice to the rights of third parties

Free format text: HOMOLOGADA A RENUNCIA DA PATENTE, SOLICITADA ATRAVES DA PETICAO DEINPI/RJ NO 020140004672 DE 03/02/2014.